| Phase 3 |
| NCT07023315 |
A Phase III Clinical Study of Cadonilimab Plus SOX as Perioperative Treatment for… |
Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma |
Recruiting |
| NCT06951503 |
AK112 and Chemotherapy in First-line Metastatic Colorectal Cancer |
Colorectal Adenocarcinoma |
Recruiting |
| NCT06953999 |
A Phase III Study of Ivonescimab + Chemo With/Without AK117 in Metastatic Pancreatic… |
Pancreatic Cancer |
Recruiting |
| NCT07010263 |
A Study of AK112 as Consolidation Treatment for Patients With Limited Stage Small-cell… |
Small Cell Lung Cancer |
Recruiting |
| NCT06767527 |
AK112 or Placebo Plus Nab-Paclitaxel as First-line Treatment in Inoperable Locally… |
Triple-Negative Breast Cancer (TNBC) |
Recruiting |
| NCT06928389 |
Ivonescimab in Combination With Docetaxel in Advanced Non-Small Cell Lung Cancer |
Non-Small Cell Lung Cancer |
Recruiting |
| NCT07412613 |
Neoadjuvant/Adjuvant AK104 in Microsatellite Instability-high or Mismatch… |
Resectable Colon Cancer |
Recruiting |
| NCT06591520 |
AK112 Combined With Chemotherapy Versus Durvalumab Combined With Chemotherapy in Advanced… |
Biliary Tract Cancer |
Active, Not Recruiting |
| NCT05184712 |
Phase 3 Clinical Study of AK112 for NSCLC Patients |
Non-Squamous Non-small Cell Lung Cancer |
Active, Not Recruiting |
| NCT07449780 |
A Study of AK104 (SC) in Combination With Oxaliplatin and Capecitabine (XELOX) Versus… |
Gastric / Gastroesophageal Junction Adenocarcinoma |
Not Yet Recruiting |
| NCT05499390 |
AK112 in Advanced Non-Small Cell Lung Cancer |
Advanced Non-small-cell Lung Cancer |
Active, Not Recruiting |
| Phase 2 |
| NCT07263919 |
Perioperative Cadonilimab Combined With Neoadjuvant Chemotherapy in Resectable Esophageal… |
Resectable Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma |
Recruiting |
| NCT07114315 |
A Study of AK130 in Combination With AK112 for the Treatment of Advanced Pancreatic Cancer |
Pancreatic Cancer |
Recruiting |
| NCT07052253 |
A Phase II Clinical Study of AK104/AK112 in Combination With TT-00420 Tablet for Advanced… |
Hepatocellular Carcinoma (HCC) |
Recruiting |
| NCT07436221 |
A Study to Evaluate the Efficacy and Safety of AK139 in Participants With Asthma |
Asthma |
Not Yet Recruiting |
| NCT07436234 |
A Study to Evaluate the Efficacy and Safety of AK139 in Participants With Seasonal… |
Seasonal Allergic Rhinitis |
Not Yet Recruiting |
| NCT04736823 |
A Trial of AK112 (PD1/VEGF Bispecific) in Combination With Chemotherapy in Patients With… |
NSCLC |
Active, Not Recruiting |
| NCT05247684 |
AK112 Neoadjuvant/Adjuvant Treatment for Resectable NSCLC |
Resectable Non-small Cell Lung Cancer |
Active, Not Recruiting |
| NCT05227664 |
A Study of AK117/AK112 in Metastatic Triple-Negative Breast Cancer |
Metastatic Triple-negative Breast Cancer |
Active, Not Recruiting |
| NCT07502222 |
A Study to Evaluate the Efficacy and Safety of AK139 in Patients With Moderate-to-severe… |
Moderate-to-Severe Atopic Dermatitis |
Not Yet Recruiting |
| NCT07591090 |
A Phase II Study of AK146D1 Combined With AK112 in Advanced Breast Cancer |
Advanced Breast Cancer |
Not Yet Recruiting |
| NCT07636772 |
A Phase II Study of AK146D1 Mono or Combined With AK112 in Advanced Urothelial Carcinoma |
Urothelial Carcinoma (UC) |
Not Yet Recruiting |
| Phase 1/2 |
| NCT06938321 |
A Study of AK130 in Combination With AK112 for the Treatment of Advanced Biliary Tract… |
Biliary Tract Cancer |
Recruiting |
| NCT06530251 |
A Study of AK112 in Patients With Advanced Hepatocellular Carcinoma (HCC) |
Hepatocellular Carcinoma |
Recruiting |
| NCT05689853 |
Study of AK119 Combined With AK112 in Patients With Advanced Solid Tumors |
Solid Tumor, Adult |
Recruiting |